Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiyuan Medicine is a China-based biopharmaceutical company focused on the development of innovative therapies, particularly in the fields of women's health and traditional Chinese medicine (TCM) modernization. The company is best known for its development of Xiyuan-1 (also known as Kuntai Capsule or related derivatives), which targets menopausal symptoms and hormonal imbalances. Xiyuan Medicine integrates modern pharmacological research with traditional herbal knowledge to create standardized, evidence-based treatments. Their pipeline primarily addresses gynecological conditions and age-related metabolic disorders through small molecule and botanical-derived candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiyuan Medicine.